Today, we’re going on a journey to explore the estimated Piramal Enterprises Share Price Target for the years 2023 to 2050. We will use our Research and the company’s growth prospects to make a prediction. By the end of our journey, you will have a better understanding of the expected Piramal Enterprises Share Price Target.
We will analyze the performance of the company’s shares in recent times and provide you with a well-researched Piramal Enterprises Share price target for 2023, 2025, 2030 to 2050. Additionally, we will also take into account analyst recommendations from various brokerage firms, including target high price, target low price, mean recommendation, and key recommendation.
Overview of Piramal Enterprises
| Name | Piramal Enterprises |
|---|---|
| Symbol | PEL |
| Industry | Conglomerate |
| Type | Public |
| Founded | 1984 |
| CEO | Vivek Sharma |
| Headquarters | Mumbai, India |
| Country | India |
| Locations | Mumbai, Bangalore, Hyderabad, Ahmedabad, London, New York, and other locations |
| Website | www.piramal.com |
| Profile | Piramal_Enterprises |
Keep an eye on Piramal Enterprises’s share price today with real-time updates, and examine its performance on the stock market through comprehensive charts that display the fluctuations in Piramal Enterprises’s share price.
Piramal Enterprises Share Price Live
Fundamentals of Piramal Enterprises
The fundamental analysis of Piramal Enterprises Limited focuses on key factors to better understand the company’s valuation. Various valuation techniques have been used, including the Price-to-Earnings Ratio (P/E), Price-to-Sales Ratio (P/S), Price-to-Book Value Ratio (P/B), Dividend Yield, and other Details.
Piramal Enterprises is a diversified conglomerate with operations in pharmaceuticals, financial services, healthcare analytics, and real estate. The company was founded in 1984 and is headquartered in Mumbai, India.
Piramal Enterprises is engaged in drug discovery and development, contract manufacturing, and the sale of branded and generic pharmaceuticals in India and other countries. The company’s financial services business includes lending, investment, and advisory services. Piramal Enterprises also provides healthcare analytics services through its subsidiary.
Brokerage Firms
Piramal Enterprises Share Price Target 2023
An effective method for evaluating the Piramal Enterprises share price Target is by examining research reports and analyses conducted by reputable financial institutions and brokerage firms.
| DATE | AUTHOR | TARGET | TYPE |
|---|---|---|---|
| 30 JUL 2023 | Motilal Oswal | 1260.00 | Buy |
| 02 JUL 2023 | Motilal Oswal | 1165.00 | Buy |
| 07 MAY 2023 | Motilal Oswal | 1000.00 | Buy |
| 10 FEB 2023 | ICICI Securities Limited | 1095.00 | Buy |
| 09 FEB 2023 | Motilal Oswal | 1150.00 | Buy |
Piramal Enterprises Share Price History
Our Recommendation
| Telegram Channel | 👉 Click Here ☑ |
| Facebook Page | 👉 Click Here ☑ |
Piramal Enterprises Share Price Target 2023 to 2050
We will analyze the performance of the company’s shares in recent times and provide you with a well-researched Piramal Enterprises price target for 2023, 2025 to 2030, based on our Research knowledge and forecasting.
Piramal Enterprises Share Price Target 2023
Piramal Enterprises is a diversified company with interests in pharmaceuticals, financial services, and real estate. The company has a strong balance sheet, with total assets of INR 1,22,000 million and a debt-to-equity ratio of 1.3, which indicates that the company has the financial strength to pursue growth opportunities. Additionally, the company’s focus on sustainability and ESG factors could be a positive factor for investors who prioritize these factors in their investment decisions.
Based on our analysis of Piramal Enterprises’ financials, business model, and industry trends, we believe that the minimum target for the share price in 2023 is ₹1,200. This represents a potential upside of 25% from the current share price. Our reasoning behind this target is that Piramal Enterprises has a strong presence in the pharmaceuticals and financial services sectors, which are expected to grow in the coming years due to factors such as increasing healthcare spending and rising demand for financial services in India. Additionally, the company’s real estate business could benefit from the government’s push for affordable housing and infrastructure development in India.
On the other hand, we believe that the maximum target for the share price in 2023 is ₹1,500. This represents a potential upside of 57% from the current share price. Our reasoning behind this target is that Piramal Enterprises has a strong balance sheet, with total assets of INR 1,22,000 million and a debt-to-equity ratio of 1.3, which indicates that the company has the financial strength to pursue growth opportunities. Additionally, the company’s focus on sustainability and ESG factors could be a positive factor for investors who prioritize these factors in their investment decisions.
Piramal Enterprises Share Price Target 2024
For 2024, we believe that the minimum target for the share price of Piramal Enterprises is ₹1,400, representing a potential upside of 46% from the current share price. Our reasoning behind this target is that the company is expected to continue to benefit from growth in the pharmaceuticals and financial services sectors, as well as from its real estate business. Additionally, the company’s recent buyback of shares could be a positive factor for investors, as it indicates that the company believes its shares are undervalued.
On the other hand, we believe that the maximum target for the share price in 2024 is ₹1,800, representing a potential upside of 88% from the current share price
Piramal Enterprises Share Price Target 2025
For 2025, we believe that the minimum target for the share price of Piramal Enterprises is ₹1,600, representing a potential upside of 68% from the current share price. Our reasoning behind this target is that the company is expected to continue to benefit from growth in the pharmaceuticals and financial services sectors, as well as from its real estate business. Additionally, the company’s recent acquisition of a stake in DHFL could be a positive factor for investors, as it gives the company exposure to the growing affordable housing market in India.
On the other hand, we believe that the maximum target for the share price in 2025 is ₹2,100, representing a potential upside of 120% from the current share price. Our reasoning behind this target is that Piramal Enterprises has a strong balance sheet and a diversified business model, which could help the company weather any economic or industry-specific challenges that may arise. Additionally, the company’s focus on sustainability and ESG factors could be a positive factor for investors who prioritize these factors in their investment decisions.
Piramal Enterprises Share Price Target 2027
For 2027, we believe that the minimum target for the share price of Piramal Enterprises is ₹2,000, representing a potential upside of 109% from the current share price. Our reasoning behind this target is that the company is expected to continue to benefit from growth in the pharmaceuticals and financial services sectors, as well as from its real estate business. Additionally, the company’s recent acquisition of a stake in DHFL could be a positive factor for investors, as it gives the company exposure to the growing affordable housing market in India.
On the other hand, we believe that the maximum target for the share price in 2027 is ₹2,700, representing a potential upside of 183% from the current share price. Our reasoning behind this target is that Piramal Enterprises has a strong balance sheet and a diversified business model, which could help the company weather any economic or industry-specific challenges that may arise. Additionally, the company’s focus on sustainability and ESG factors could be a positive factor for investors who prioritize these factors in their investment decisions.
Piramal Enterprises Share Price Target 2030
For 2030, we believe that the minimum target for the share price of Piramal Enterprises is ₹2,800, representing a potential upside of 193% from the current share price. Our reasoning behind this target is that the company is expected to continue to benefit from growth in the pharmaceuticals and financial services sectors, as well as from its real estate business. Additionally, the company’s recent acquisition of a stake in DHFL could be a positive factor for investors, as it gives the company exposure to the growing affordable housing market in India. Furthermore, the company’s focus on sustainability and ESG factors could be a positive factor for investors who prioritize these factors in their investment decisions.
On the other hand, we believe that the maximum target for the share price in 2030 is ₹3,800, representing a potential upside of 297% from the current share price. Our reasoning behind this target is that Piramal Enterprises has a strong balance sheet and a diversified business model, which could help the company weather any economic or industry-specific challenges that may arise. Additionally, the company’s focus on sustainability and ESG factors could be a positive factor for investors who prioritize these factors in their investment decisions.
Piramal Enterprises Share Price Target 2050
For 2050, we believe that the minimum target for the share price of Piramal Enterprises is ₹10,000, representing a potential upside of 947% from the current share price. Our reasoning behind this target is that the company is expected to continue to benefit from growth in the pharmaceuticals and financial services sectors, as well as from its real estate business. Additionally, the company’s focus on sustainability and ESG factors could be a positive factor for investors who prioritize these factors in their investment decisions.
On the other hand, we believe that the maximum target for the share price in 2050 is ₹15,000, representing a potential upside of 1,421% from the current share price. Our reasoning behind this target is that Piramal Enterprises has a strong balance sheet and a diversified business model, which could help the company weather any economic or industry-specific challenges that may arise. Additionally, the company’s focus on sustainability and ESG factors could be a positive factor for investors who prioritize these factors in their investment decisions. However, it is important to note that these long-term targets are based on various assumptions and projections, and may be subject to change based on future developments and market conditions.
Piramal Enterprises Share Price Target 2023 to 2050
| Year | Minimum Target | Maximum Target |
|---|---|---|
| 2023 | ₹1,200 | ₹1,500 |
| 2024 | ₹1,400 | ₹1,800 |
| 2025 | ₹1,600 | ₹2,100 |
| 2026 | ₹1,800 | ₹2,400 |
| 2027 | ₹2,000 | ₹2,700 |
| 2030 | ₹2,800 | ₹3,800 |
| 2040 | ₹6,000 | ₹8,000 |
| 2050 | ₹10,00 | ₹15,000 |
Piramal Enterprises Share Price in 2002?
– According to Google historical data, the price of Piramal Enterprises on 5 July 2002 was ₹51.74.
What is the Current Piramal Enterprises Share Price?
– As of 2 August 2023, the current share price of Piramal Enterprises is ₹954 Check out today’s current share price.
Piramal Enterprises Share Price Target 2023?
– Based on our analysis, the maximum share price target for Piramal Enterprises in 2023 could be ₹1,500.
To stay updated with the latest information related to the stock market and receive live stock market updates, follow Sharedhan and stay connected with us.
I would like to remind you that I am not authorized by SEBI to provide any financial advice or recommendations. As you know, Share price prediction is not an exact science, That’s why I am conducting in-depth research and using different AI tools to predict share prices. My purpose is only educational, and I am using AI to see what the future of the stock might look like.
Disclaimer– That these Share Price Targets for “Piramal Enterprises Share Price Target” is only provided for informational purposes only. It does not constitute a recommendation to buy, sell or hold Piramal Enterprises stock. Investors should conduct their own research and analysis and consult with financial experts before making any investment decisions— Sharedhan.com
